FDA Chief Nominee: Lines Must Divide Medical Product Review, Public Partnerships

FDA commissioner nominee Robert Califf called for clear divisions between the agency's joint ventures with industry and the clinical operations of the agency, stressing a need to protect FDA's gold standard for medical product reviews. Califf also discussed the importance patient voice will play in drug development moving forward and suggested the agency will place greater emphasis on real-world data, speaking recently at the annual meeting for one of FDA’s largest public partnerships with industry and stakeholders. “There is really...